Sieveking Ageless Solutions, LLC – Trademark Portfolio
Entity Type: 16
Sieveking Ageless Solutions, LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include THE CLINIC OF AGELESS SOLUTIONS. The owner is based in Nashville, TN.
204 23rd Avenue North
Nashville, TN 372031502
Showing of trademarks Trademarks
Trademark Classifications
Sieveking Ageless Solutions, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Sieveking Ageless Solutions, LLC have?
Sieveking Ageless Solutions, LLC has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 cancelled.
What trademark classes does Sieveking Ageless Solutions, LLC file in?
Sieveking Ageless Solutions, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Sieveking Ageless Solutions, LLC's most well-known trademarks?
Sieveking Ageless Solutions, LLC's registered trademark portfolio includes well-known marks such as THE CLINIC OF AGELESS SOLUTIONS. These are among 1 currently registered trademark in the portfolio.
What is Sieveking Ageless Solutions, LLC's trademark registration success rate?
Sieveking Ageless Solutions, LLC has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.